|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.282
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.248
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.213
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.210
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.202
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.196
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.155
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.144
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.140
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.138
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.135
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.133
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.133
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.127
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.120
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.114
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.114
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.113
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.112
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.110
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.109
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.107
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.101
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.101
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.099
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.093
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.091
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.085
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.081
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.081
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.080
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.079
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.073
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.073
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.070
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.067
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.067
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.066
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.065
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.065
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.059
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.058
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.057
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.057
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.055
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.053
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.053
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.053
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.053
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.052
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.052
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.051
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.051
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.050
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.050
|
|
|
|
ketone catabolic process
|
GO:0042182 |
3 |
0.048
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.048
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.048
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.047
|
Human |
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.047
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.047
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.046
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.046
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.045
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.044
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.043
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.042
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.042
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.042
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.042
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.042
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.041
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.041
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.040
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.040
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.039
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.039
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.038
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.038
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.038
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.038
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.037
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.037
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.036
|
|
|
|
vegf activated neuropilin signaling pathway involved in axon guidance
|
GO:1902378 |
1 |
0.035
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.035
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.035
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.035
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.034
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.033
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.033
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.033
|
|
|
|
negative regulation of glycoprotein metabolic process
|
GO:1903019 |
3 |
0.033
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.032
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.032
|
|
|
|
phototransduction
|
GO:0007602 |
17 |
0.032
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.032
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.032
|
|
|
|
regulation of transposition
|
GO:0010528 |
2 |
0.032
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.031
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.031
|
|
|
|
sleep
|
GO:0030431 |
7 |
0.031
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.031
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron development
|
GO:0021888 |
4 |
0.031
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.031
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.031
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.030
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.030
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.029
|
|
|
|
negative regulation of transposition
|
GO:0010529 |
2 |
0.029
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.029
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.029
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.028
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.028
|
|
|
|
glycoprotein catabolic process
|
GO:0006516 |
5 |
0.028
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.028
|
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.028
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.028
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.027
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.027
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.027
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.026
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.026
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.026
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.026
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.026
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.026
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.026
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.026
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.025
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.025
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.025
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.025
|
|
|
|
facioacoustic ganglion development
|
GO:1903375 |
3 |
0.025
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.023
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.023
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.023
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.023
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.023
|
|
|
|
positive regulation of protein export from nucleus
|
GO:0046827 |
4 |
0.023
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.023
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.022
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.022
|
|
|
|
sensory neuron axon guidance
|
GO:0097374 |
3 |
0.022
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.022
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.022
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.022
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.022
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.022
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.021
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.021
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.021
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.021
|
Human |
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.021
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.021
|
|
|
|
sertoli cell differentiation
|
GO:0060008 |
18 |
0.021
|
|
|
|
glycosphingolipid metabolic process
|
GO:0006687 |
18 |
0.021
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.021
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.021
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.021
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.021
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.021
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.020
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.020
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.020
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.020
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.020
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.020
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.020
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.020
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.020
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.020
|
|
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.020
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.020
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.019
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.019
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
male courtship behavior
|
GO:0008049 |
2 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.018
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.018
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.018
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.018
|
|
|
|
facial nerve development
|
GO:0021561 |
11 |
0.018
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.018
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.018
|
Human |
|
|
nerve development
|
GO:0021675 |
67 |
0.018
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
regulation of polyamine transmembrane transport
|
GO:1902267 |
5 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.018
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.017
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.017
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.017
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.017
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.017
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.017
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.017
|
|
|
|
sertoli cell development
|
GO:0060009 |
15 |
0.017
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.017
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
ceramide catabolic process
|
GO:0046514 |
7 |
0.017
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.017
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.017
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.016
|
|
|
|
water soluble vitamin biosynthetic process
|
GO:0042364 |
3 |
0.016
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.016
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.016
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.016
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.016
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron differentiation
|
GO:0021886 |
4 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.016
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.016
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.016
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.016
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.016
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.016
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.016
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.016
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.016
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.015
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.015
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.015
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.015
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.015
|
|
|
|
substrate dependent cerebral cortex tangential migration
|
GO:0021825 |
3 |
0.015
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.015
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.015
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.015
|
|
|
|
polyamine transmembrane transport
|
GO:1902047 |
5 |
0.015
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.015
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.015
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.015
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.015
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.015
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.015
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.015
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
|
adaptation of rhodopsin mediated signaling
|
GO:0016062 |
2 |
0.015
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.015
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.015
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.015
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.015
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.015
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.015
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.015
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.015
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.015
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.015
|
|
|
|
protein localization to early endosome
|
GO:1902946 |
1 |
0.015
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.014
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.014
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.014
|
|
|
|
rhythmic behavior
|
GO:0007622 |
15 |
0.014
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.014
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.014
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.014
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.014
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.014
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.014
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.014
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.014
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.014
|
|
|
|
light adaption
|
GO:0036367 |
2 |
0.014
|
|
|
|
trigeminal nerve development
|
GO:0021559 |
10 |
0.014
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.014
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.014
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.014
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.014
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.014
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
glossopharyngeal nerve morphogenesis
|
GO:0021615 |
4 |
0.014
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.014
|
|
|
|
cranial nerve structural organization
|
GO:0021604 |
13 |
0.014
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.014
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.014
|
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.014
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.014
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.013
|
|
|
|
visual learning
|
GO:0008542 |
44 |
0.013
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.013
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.013
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.013
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.013
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.013
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.013
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.013
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.013
|
|
|
|
ganglion morphogenesis
|
GO:0061552 |
2 |
0.013
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.013
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.013
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.013
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.013
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.013
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.013
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.013
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.013
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.013
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.013
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.013
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.012
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.012
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.012
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.012
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
|
trigeminal nerve morphogenesis
|
GO:0021636 |
6 |
0.012
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.012
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.012
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.012
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.012
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.012
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.012
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.012
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.012
|
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.012
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.012
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.012
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.012
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.012
|
|
|
|
hypothalamus cell migration
|
GO:0021855 |
5 |
0.012
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.012
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.012
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.012
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.012
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.012
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.012
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.012
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.012
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.012
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.012
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.012
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.012
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.012
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.012
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.012
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.012
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.012
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.011
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.011
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.011
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.011
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.011
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.011
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.011
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.011
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.011
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.011
|
|
|
|
positive regulation of rac gtpase activity
|
GO:0032855 |
14 |
0.011
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.011
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.011
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.011
|
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.011
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.011
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.011
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.011
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.011
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.011
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.011
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.011
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.011
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.011
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.011
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.011
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.011
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.011
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.011
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.011
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.011
|
|
|
|
modulation by virus of host morphology or physiology
|
GO:0019048 |
3 |
0.010
|
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.010
|
|
|
|
collagen catabolic process
|
GO:0030574 |
6 |
0.010
|
|
|
|
pyrimidine nucleobase metabolic process
|
GO:0006206 |
3 |
0.010
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.010
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.010
|
|
|
|
neuropilin signaling pathway
|
GO:0038189 |
2 |
0.010
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.010
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.010
|
|
|
|
adherens junction maintenance
|
GO:0034334 |
1 |
0.010
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.010
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.010
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.010
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.010
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.010
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.010
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.010
|
|
|
|
detection of muscle stretch
|
GO:0035995 |
1 |
0.010
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.010
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.010
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.010
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.010
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.010
|
|
|
|
positive regulation of lamellipodium organization
|
GO:1902745 |
3 |
0.010
|
|